Short Term Effect of Empagliflozin in Hypertension

Sponsor
Yaounde Central Hospital
Study ID
NCT04203914
Phase
PHASE4
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
21 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The investigators assessed the 6-week effect of once daily 25mg SGLT2-i Empagliflozin on left ventricular diastolic function and blood pressure profile in non diabetic hypertensive patients

Key Dates

Start date
Jan 10, 2017
Status verified
Dec 2019
Primary completion
May 30, 2017
Completion
Sep 30, 2017

Study Design

Enrollment
15 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Intervention
    Empagliflozin 25mg daily add-on therapy

Primary Outcome Measure

Left ventricular diastolic function [ Time Frame: 6 weeks ]

Related Studies